Compare BioNTech SE - ADR (BNTX) vs Ecolab Inc. (ECL) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
BioNTech SE - ADR vs Ecolab Inc. — how do they compare? BioNTech SE - ADR trades at $89.76 (market cap $22.78B), while Ecolab Inc. trades at $269.19 (market cap $76.51B). The key difference: Ecolab Inc. is far larger — about 3.4× BioNTech SE - ADR's market cap, and Ecolab Inc. pays a 1.07% dividend while BioNTech SE - ADR pays none. Which is the better fit depends on your goals.
| BNTX | ECL | |
|---|---|---|
Market Cap | $22.78B | $76.51B |
Sector | Health | Consumer Cyclical |
52-Week High | $119.34 | $308.35 |
52-Week Low | $83.89 | $245.73 |
Enterprise Value | $6.45B | $85.26B |
Dividend Yield | — | 1.07% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About BioNTech SE - ADR
BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including COVID-19. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens, neoantigens, cytokines, and antibodies.
Read more on BNTX →About Ecolab Inc.
Ecolab produces and markets cleaning and sanitation products for the hospitality, healthcare, and industrial markets. The firm is the global market share leader in this category with a wide array of products and services, including dish and laundry washing systems, pest control, and infection control products. The company has a strong hold on the U.S. market and is looking to increase its profitability abroad. Additionally, Ecolab serves customers in water, manufacturing, and life sciences end markets, selling customized solutions.
Read more on ECL →
